SafeHer Phase III study primary analysis: Safety of subcutaneous trastuzumab plus chemotherapy for early breast cancer

Affiliation auteursAffiliation ok
TitreSafeHer Phase III study primary analysis: Safety of subcutaneous trastuzumab plus chemotherapy for early breast cancer
Type de publicationJournal Article
Year of Publication2016
AuteursGligorov J., Ataseven B., Verrill M., De Laurentiis M., Jung K.H, Azim H.A, Al-Sakaff N., Lauer S., Shing M., Pivot X.
JournalEUROPEAN JOURNAL OF CANCER
Volume57
PaginationS89-S90
Date PublishedAPR
Type of ArticleMeeting Abstract
ISSN0959-8049